DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,466,114 | -55.1% | 9,940 | -56.6% | 0.19% | -52.8% |
| Q2 2023 | $5,490,960 | -42.0% | 22,879 | -39.1% | 0.41% | -47.2% |
| Q1 2023 | $9,470,403 | -8.8% | 37,575 | -3.9% | 0.78% | -20.0% |
| Q4 2022 | $10,379,515 | +8.4% | 39,106 | +5.5% | 0.97% | +8.7% |
| Q3 2022 | $9,572,000 | +23.9% | 37,061 | +21.6% | 0.89% | +31.5% |
| Q2 2022 | $7,724,000 | +14.4% | 30,466 | +32.3% | 0.68% | +38.2% |
| Q1 2022 | $6,753,000 | +101.5% | 23,021 | +126.0% | 0.49% | +128.8% |
| Q4 2021 | $3,352,000 | +71.9% | 10,187 | +59.0% | 0.22% | +51.4% |
| Q3 2021 | $1,950,000 | +13.4% | 6,406 | 0.0% | 0.14% | +17.4% |
| Q2 2021 | $1,719,000 | +19.2% | 6,406 | 0.0% | 0.12% | +8.0% |
| Q1 2021 | $1,442,000 | -2.8% | 6,406 | -4.1% | 0.11% | +7.7% |
| Q4 2020 | $1,484,000 | +3.1% | 6,681 | 0.0% | 0.10% | -8.0% |
| Q3 2020 | $1,439,000 | +23.1% | 6,681 | +1.0% | 0.11% | +9.7% |
| Q2 2020 | $1,169,000 | +33.3% | 6,612 | +4.3% | 0.10% | +3.0% |
| Q1 2020 | $877,000 | -9.9% | 6,337 | 0.0% | 0.10% | +11.1% |
| Q4 2019 | $973,000 | +6.3% | 6,337 | 0.0% | 0.09% | -2.2% |
| Q3 2019 | $915,000 | +1.0% | 6,337 | 0.0% | 0.09% | -3.2% |
| Q2 2019 | $906,000 | +8.2% | 6,337 | 0.0% | 0.10% | +5.6% |
| Q1 2019 | $837,000 | +28.2% | 6,337 | 0.0% | 0.09% | +11.1% |
| Q4 2018 | $653,000 | -5.4% | 6,337 | -0.2% | 0.08% | +9.5% |
| Q3 2018 | $690,000 | +10.0% | 6,352 | 0.0% | 0.07% | +1.4% |
| Q2 2018 | $627,000 | +4.3% | 6,352 | +3.4% | 0.07% | 0.0% |
| Q1 2018 | $601,000 | -1.2% | 6,141 | -6.2% | 0.07% | -1.4% |
| Q4 2017 | $608,000 | +8.2% | 6,550 | 0.0% | 0.07% | +1.4% |
| Q3 2017 | $562,000 | +1.6% | 6,550 | 0.0% | 0.07% | -1.4% |
| Q2 2017 | $553,000 | -1.2% | 6,550 | 0.0% | 0.07% | -6.3% |
| Q1 2017 | $560,000 | +9.8% | 6,550 | 0.0% | 0.08% | +1.3% |
| Q4 2016 | $510,000 | -0.6% | 6,550 | 0.0% | 0.08% | +1.3% |
| Q3 2016 | $513,000 | -22.5% | 6,550 | 0.0% | 0.08% | -27.4% |
| Q2 2016 | $662,000 | +6.6% | 6,550 | 0.0% | 0.11% | +7.1% |
| Q1 2016 | $621,000 | +2.1% | 6,550 | 0.0% | 0.10% | 0.0% |
| Q4 2015 | $608,000 | +9.0% | 6,550 | 0.0% | 0.10% | +2.1% |
| Q3 2015 | $558,000 | -0.4% | 6,550 | 0.0% | 0.10% | +7.8% |
| Q2 2015 | $560,000 | +0.7% | 6,550 | 0.0% | 0.09% | 0.0% |
| Q1 2015 | $556,000 | +0.5% | 6,550 | +1.6% | 0.09% | +1.1% |
| Q4 2014 | $553,000 | +12.9% | 6,450 | 0.0% | 0.09% | +9.9% |
| Q3 2014 | $490,000 | -3.5% | 6,450 | 0.0% | 0.08% | -6.9% |
| Q2 2014 | $508,000 | +5.2% | 6,450 | 0.0% | 0.09% | +1.2% |
| Q1 2014 | $483,000 | -3.0% | 6,450 | 0.0% | 0.09% | -4.4% |
| Q4 2013 | $498,000 | +11.4% | 6,450 | 0.0% | 0.09% | 0.0% |
| Q3 2013 | $447,000 | +9.6% | 6,450 | 0.0% | 0.09% | +2.3% |
| Q2 2013 | $408,000 | – | 6,450 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |